Earnings History Data for Processa Pharmaceuticals, Inc. (PCSA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-03-2023 | AH | 4:00 PM ET (Mar 30) |
PCSA | Processa Pharmaceuticals, Inc. | 17.58 | -0.35 | -0.25 | -0.21 | 0.5037 | 0.02 (4.94%) |
0.50 | 0.02 (4.17%) |
0.36 - 4.01 | 55,169 | 80,000 | 2,907 | ||
|
|
||||||||||||||||||
| 08-11-2022 | AH | 4:20 PM ET (Nov 8) |
PCSA | Processa Pharmaceuticals, Inc. | 34.25 | -0.37 | -0.34 | -0.19 | Processa Pharmaceuticals GAAP EPS of -$0.90 for 9M [11/8/2022 4:04 PM] |
2.05 | -0.10 (-4.65%) |
0.0 | 0.0 (0.00%) |
1.50 - 7.13 | 5,596 | 10,000 | 0 | |
| 12-08-2022 | PM | 4:20 PM ET (Aug 11) |
PCSA | Processa Pharmaceuticals, Inc. | 57.81 | -0.32 | -0.26 | -0.20 | Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73 [8/12/2022 10:43 AM] |
3.31 | 0.17 (5.25%) |
0.0 | 0.0 (0.00%) |
1.50 - 8.99 | 8,929 | 10,000 | 0 | |
| 12-05-2022 | AH | 4:00 PM ET (May 12) |
PCSA | Processa Pharmaceuticals, Inc. | 36.44 | -0.20 | -0.24 | -0.14 | Processa Pharmaceuticals Non-GAAP EPS of -$0.20 [5/12/2022 4:39 PM] |
1.90 | -0.05 (-2.56%) |
1.83 | 0.04 (2.23%) |
1.69 - 8.99 | 38,840 | 50,000 | 102 | |
| 30-03-2022 | AH | After the close (Mar 30) |
PCSA | Processa Pharmaceuticals, Inc. | 50.61 | -0.21 | -0.18 | -0.90 | Processa Pharmaceuticals GAAP EPS of -$0.75 misses by $0.01 [3/30/2022 4:37 PM] |
3.01 | -0.10 (-3.24%) |
3.16 | 0.05 (1.61%) |
3.00 - 11.50 | 20,465 | 20,000 | 250 | |
| 12-11-2021 | AH | 5:15 PM ET (Nov 11) |
PCSA | Processa Pharmaceuticals, Inc. | 106.27 | -0.19 | -0.21 | -0.55 | Processa Pharmaceuticals EPS misses by $0.01 [11/11/2021 4:10 PM] |
6.51 | -0.43 (-6.27%) |
6.95 | 0.01 (0.14%) |
4.25 - 14.24 | 68,450 | 60,000 | 150 | |
| 12-08-2021 | AH | 4:55 PM ET (Aug 12) |
PCSA | Processa Pharmaceuticals, Inc. | 91.37 | -0.20 | -0.15 | -0.13 | Processa Pharmaceuticals EPS misses by $0.06 [8/12/2021 5:21 PM] |
5.40 | -0.45 (-7.69%) |
5.70 | -0.15 (-2.56%) |
3.40 - 14.24 | 72,780 | 320,000 | 3,067 | |
| 13-05-2021 | AH | 6:30 PM ET (May 13) |
PCSA | Processa Pharmaceuticals, Inc. | 105.86 | -0.14 | 0.00 | -0.16 | Processa Pharmaceuticals EPS misses by $0.04 [5/13/2021 4:57 PM] |
6.29 | 0.13 (2.11%) |
6.15 | -0.01 (-0.16%) |
3.40 - 14.24 | 31,314 | 60,000 | 100 | |
| 12-11-2020 | AH | 6:30 PM ET (Nov 12) |
PCSA | Processa Pharmaceuticals, Inc. | 43.94 | -0.55 | 0.00 | -0.14 | Processa Pharmaceuticals EPS misses by $0.39 [11/12/2020 5:04 PM] |
4.25 | 0.04 (0.95%) |
4.21 | 0.0 (0.00%) |
3.40 - 18.00 | 10,181 | 20,887 | 1,000 | |
|
|
||||||||||||||||||